Literature DB >> 12681001

Prolonged low-dose caffeine exposure protects against hippocampal damage but not against the occurrence of epilepsy in the lithium-pilocarpine model in the rat.

Marie-Aude Rigoulot1, Claire Leroy, Estelle Koning, Arielle Ferrandon, Astrid Nehlig.   

Abstract

PURPOSE: Acute caffeine exposure has proconvulsant effects and worsens epileptic and ischemic neuronal damage. Surprisingly, prolonged caffeine exposure decreases the susceptibility to seizures and the extent of ischemic damage. We explored whether the exposure to a low long-term dose of caffeine could protect the brain from neuronal damage and epileptogenesis in the lithium-pilocarpine model of temporal lobe epilepsy.
METHODS: Rats received either plain tap water or water containing caffeine (0.3 g/L) for 15 days before the induction of status epilepticus (SE) by lithium-pilocarpine and for 7 days after SE. The extent of neuronal damage was assessed in the hippocampus and piriform and entorhinal cortices in brain sections stained with thionine and obtained from animals killed 7 days after SE. The latency to spontaneous recurrent seizures was controlled by video monitoring.
RESULTS: Caffeine treatment induced a marked, almost total neuroprotection in CA1 and a very limited protection in the hilus of the dentate gyrus, whereas damage in layers III-IV of the piriform cortex was slightly worsened by the treatment. All rats, whether they received caffeine or plain tap water, became epileptic after the same latency (17-19 days).
CONCLUSIONS: Thus these data extend the neuroprotective effects of low long-term caffeine exposure to epileptic damage and confirm that the sole protection of the Ammon's horn has no influence on the genesis of spontaneous recurrent seizures in this model.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12681001     DOI: 10.1046/j.1528-1157.2003.50502.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  6 in total

Review 1.  Prevention or modification of epileptogenesis after brain insults: experimental approaches and translational research.

Authors:  Wolfgang Löscher; Claudia Brandt
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

2.  Chronic caffeine treatment prevents sleep deprivation-induced impairment of cognitive function and synaptic plasticity.

Authors:  Ibrahim A Alhaider; Abdulaziz M Aleisa; Trinh T Tran; Karem H Alzoubi; Karim A Alkadhi
Journal:  Sleep       Date:  2010-04       Impact factor: 5.849

3.  Chronic caffeine treatment prevents stress-induced LTP impairment: the critical role of phosphorylated CaMKII and BDNF.

Authors:  K H Alzoubi; M Srivareerat; A M Aleisa; K A Alkadhi
Journal:  J Mol Neurosci       Date:  2012-06-16       Impact factor: 3.444

Review 4.  The Use of Caffeine by People with Epilepsy: the Myths and the Evidence.

Authors:  Prisca R Bauer; Josemir W Sander
Journal:  Curr Neurol Neurosci Rep       Date:  2019-05-14       Impact factor: 5.081

Review 5.  Neuroprotective strategies for HIV-1 associated dementia.

Authors:  Huanyu Dou; Jeffrey D Kingsley; R Lee Mosley; Harris A Gelbard; Howard E Gendelman
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

6.  Caffeine Controls Glutamatergic Synaptic Transmission and Pyramidal Neuron Excitability in Human Neocortex.

Authors:  Amber Kerkhofs; Ana C Xavier; Beatriz S da Silva; Paula M Canas; Sander Idema; Johannes C Baayen; Samira G Ferreira; Rodrigo A Cunha; Huibert D Mansvelder
Journal:  Front Pharmacol       Date:  2018-01-04       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.